OncoPro Colorectal Cancer Screen Circulating Tumor Cells Test
Revolutionary Early Detection for Colorectal Cancer
The OncoPro Colorectal Cancer Screen Circulating Tumor Cells Test represents a groundbreaking advancement in cancer diagnostics, offering a non-invasive method for detecting colorectal cancer through the analysis of circulating tumor cells (CTCs) in peripheral blood. This sophisticated molecular diagnostic approach provides unprecedented opportunities for early cancer detection when treatment outcomes are most favorable.
What Are Circulating Tumor Cells?
Circulating tumor cells are cancer cells that have detached from primary tumors and entered the bloodstream, potentially leading to metastasis. The detection and analysis of these cells provide critical insights into cancer presence, progression, and treatment response without requiring invasive procedures.
What the Test Measures and Detects
This advanced diagnostic test specifically targets and identifies circulating tumor cells associated with colorectal cancer through sophisticated molecular techniques:
- Detection of malignant epithelial cells in peripheral blood
- Identification of colorectal cancer-specific cellular markers
- Analysis of cell morphology and staining characteristics
- Quantification of circulating tumor cell burden
- Assessment of potential metastatic activity
Who Should Consider This Test
This screening test is particularly valuable for individuals experiencing concerning symptoms or those with elevated risk factors:
Symptoms Indicating Need for Testing
- Unexplained changes in bowel habits lasting more than a few days
- Persistent abdominal discomfort, cramps, or pain
- Rectal bleeding or blood in stool
- Unexplained weight loss
- Chronic fatigue and weakness
- Feeling that bowel doesn’t empty completely
Risk Factors Warranting Screening
- Family history of colorectal cancer or polyps
- Personal history of inflammatory bowel disease
- Age 45 and older (earlier for high-risk individuals)
- Genetic syndromes like Lynch syndrome or familial adenomatous polyposis
- Previous abnormal colonoscopy results
- Lifestyle factors including smoking, heavy alcohol use, or sedentary lifestyle
Benefits of Taking the OncoPro CRC Screen Test
Choosing this advanced screening method offers numerous advantages over traditional approaches:
Early Detection Capabilities
- Detects cancer at earlier, more treatable stages
- Identifies circulating tumor cells before symptoms become apparent
- Provides opportunity for intervention before metastasis occurs
Non-Invasive Procedure
- Simple blood draw eliminates need for invasive procedures
- Reduced discomfort and recovery time compared to colonoscopy
- Suitable for patients who cannot undergo traditional screening methods
Comprehensive Risk Assessment
- Provides quantitative data on circulating tumor cell presence
- Offers insights into disease progression and potential metastasis
- Supports personalized treatment planning and monitoring
Understanding Your Test Results
Proper interpretation of your OncoPro CRC Screen results is essential for making informed healthcare decisions:
Negative Result Interpretation
A negative result indicates no detectable circulating tumor cells were found in your blood sample. While this is encouraging, it does not completely rule out the presence of colorectal cancer, particularly early-stage disease or tumors that haven’t begun shedding cells into circulation.
Positive Result Interpretation
A positive result suggests the presence of circulating tumor cells associated with colorectal cancer. This finding requires immediate follow-up with your healthcare provider for comprehensive evaluation, which may include colonoscopy, imaging studies, and consultation with an oncologist.
Quantitative Results
The test provides quantitative data on the number of circulating tumor cells detected, which can help assess disease burden and guide treatment decisions. Higher cell counts may indicate more advanced disease or increased metastatic potential.
Test Pricing and Details
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $876 |
| Regular Price | $1,050 |
Additional Test Information
- Turnaround Time: 21 Working Days
- Sample Type: 10 mL whole blood in Lavender Top (EDTA) tube
- Methodology: Extraction and Staining Techniques
- Specialty: Oncologist
- Department: Molecular Diagnostics
Nationwide Testing Availability
We have conveniently located testing centers across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our extensive network ensures that advanced colorectal cancer screening is accessible to patients nationwide.
Take Action for Your Health Today
Early detection saves lives. Don’t wait for symptoms to appear before taking proactive steps toward colorectal cancer screening. The OncoPro CRC Screen Circulating Tumor Cells Test provides a sophisticated, non-invasive approach to cancer detection that could make a critical difference in your health outcomes.
Book your test today by calling or texting our dedicated healthcare line: +1(267) 388-9828
Our experienced healthcare coordinators are available to answer your questions, schedule your appointment, and guide you through the testing process. Take control of your health with the most advanced colorectal cancer screening technology available.
